These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 39047223)

  • 1. FOXP4 is a Direct YAP1 Target that Promotes Gastric Cancer Stemness and Drives Metastasis.
    Liu X; Chen B; Xie F; Wong KY; Cheung AH; Zhang J; Wu Q; Fang C; Hu J; Wang S; Xu D; Chen J; Wang Y; Wong CC; Chen H; Wu WKK; Yu J; Chan MWY; Tsang CM; Lo KW; Tse GMK; To KF; Kang W
    Cancer Res; 2024 Jul; ():. PubMed ID: 39047223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NUSAP1 Promotes Gastric Cancer Tumorigenesis and Progression by Stabilizing the YAP1 Protein.
    Guo H; Zou J; Zhou L; Zhong M; He Y; Huang S; Chen J; Li J; Xiong J; Fang Z; Xiang X
    Front Oncol; 2020; 10():591698. PubMed ID: 33489890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
    Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
    Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. H. pylori-induced NF-κB-PIEZO1-YAP1-CTGF axis drives gastric cancer progression and cancer-associated fibroblast-mediated tumour microenvironment remodelling.
    Chen B; Liu X; Yu P; Xie F; Kwan JSH; Chan WN; Fang C; Zhang J; Cheung AHK; Chow C; Leung GWM; Leung KT; Shi S; Zhang B; Wang S; Xu D; Fu K; Wong CC; Wu WKK; Chan MWY; Tang PMK; Tsang CM; Lo KW; Tse GMK; Yu J; To KF; Kang W
    Clin Transl Med; 2023 Nov; 13(11):e1481. PubMed ID: 37983931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF18-FGFR2 signaling triggers the activation of c-Jun-YAP1 axis to promote carcinogenesis in a subgroup of gastric cancer patients and indicates translational potential.
    Zhang J; Wong CC; Leung KT; Wu F; Zhou Y; Tong JHM; Chan RCK; Li H; Wang Y; Yan H; Liu L; Wu WKK; Chan MWY; Cheng ASL; Yu J; Wong N; Lo KW; To KF; Kang W
    Oncogene; 2020 Oct; 39(43):6647-6663. PubMed ID: 32934314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine kinase SRC-induced YAP1-KLF5 module regulates cancer stemness and metastasis in triple-negative breast cancer.
    Zou H; Luo J; Guo Y; Tong T; Liu Y; Chen Y; Xiao Y; Ye L; Zhu C; Deng L; Wang B; Pan Y; Li P
    Cell Mol Life Sci; 2023 Jan; 80(2):41. PubMed ID: 36633714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis.
    Zhou Y; Zhang J; Li H; Huang T; Wong CC; Wu F; Wu M; Weng N; Liu L; Cheng ASL; Yu J; Wong N; Lo KW; Tang PMK; Kang W; To KF
    Oncogene; 2020 May; 39(22):4375-4389. PubMed ID: 32313226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Hippo Pathway in Gastric Cancer and Other Malignancies in the Digestive System: From Bench to Bedside.
    Liu X; Wang Y; Chen B; Chan WN; Mui CW; Cheung AHK; Zhang J; Wong KY; Yu J; Kang W; To KF
    Biomedicines; 2022 Oct; 10(10):. PubMed ID: 36289774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA LINC00649 regulates YES-associated protein 1 (YAP1)/Hippo pathway to accelerate gastric cancer (GC) progression via sequestering miR-16-5p.
    Wang H; Di X; Bi Y; Sun S; Wang T
    Bioengineered; 2021 Dec; 12(1):1791-1802. PubMed ID: 33975517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transcription factor RUNX2 fuels YAP1 signaling and gastric cancer tumorigenesis.
    Guo Z; Zhou K; Wang Q; Huang Y; Ji J; Peng Y; Zhang X; Zheng T; Zhang Z; Chong D; Yang Z
    Cancer Sci; 2021 Sep; 112(9):3533-3544. PubMed ID: 34160112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma.
    Song S; Li Y; Xu Y; Ma L; Pool Pizzi M; Jin J; Scott AW; Huo L; Wang Y; Lee JH; Bhutani MS; Weston B; Shanbhag ND; Johnson RL; Ajani JA
    Mol Oncol; 2020 Jun; 14(6):1410-1426. PubMed ID: 32175692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Helicobacter pylori-induced aberrant demethylation and expression of GNB4 promotes gastric carcinogenesis via the Hippo-YAP1 pathway.
    Liu D; Liu Y; Zhu W; Lu Y; Zhu J; Ma X; Xing Y; Yuan M; Ning B; Wang Y; Jia Y
    BMC Med; 2023 Apr; 21(1):134. PubMed ID: 37016382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the hippo signaling pathway in human gastric cancer.
    Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
    Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RP11-323N12.5 promotes the malignancy and immunosuppression of human gastric cancer by increasing YAP1 transcription.
    Wang J; Huang F; Shi Y; Zhang Q; Xu S; Yao Y; Jiang R
    Gastric Cancer; 2021 Jan; 24(1):85-102. PubMed ID: 32623586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. USP49 mediates tumor progression and poor prognosis through a YAP1-dependent feedback loop in gastric cancer.
    Liu Z; Li J; Ding Y; Ma M; Chen J; Lei W; Li L; Yao Y; Yu X; Zhong M; Liao Q; Fang W; Fan L; Huang C; Zhong H; Wen Q; Fang Z; Chen J; Huang S; Xiong J; Xiang X; Deng J
    Oncogene; 2022 Apr; 41(18):2555-2570. PubMed ID: 35318441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YAP1-CPNE3 positive feedback pathway promotes gastric cancer cell progression.
    Li X; Zhong H; Shi Q; Ruan R; Huang C; Wen Q; Zeng S; Xia Y; Zeng Q; Xiong J; Wang S; Chen J; Lei W; Deng J
    Cell Mol Life Sci; 2024 Mar; 81(1):143. PubMed ID: 38493426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanotransduction and Cytoskeleton Remodeling Shaping YAP1 in Gastric Tumorigenesis.
    Zhang J; Zhou Y; Tang PMK; Cheng ASL; Yu J; To KF; Kang W
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARδ Interacts with the Hippo Coactivator YAP1 to Promote SOX9 Expression and Gastric Cancer Progression.
    Song S; Wang Z; Li Y; Ma L; Jin J; Scott AW; Xu Y; Estrella JS; Song Y; Liu B; Johnson RL; Ajani JA
    Mol Cancer Res; 2020 Mar; 18(3):390-402. PubMed ID: 31796534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2-IGF1R and Hippo-YAP1 signaling pathways.
    Zhang J; Chen B; Li H; Wang Y; Liu X; Wong KY; Chan WN; Chan AK; Cheung AH; Leung KT; Dong Y; Pan Y; Ke H; Liang L; Zhou Z; Xiao J; Wong CC; Wu WK; Cheng AS; Ma BB; Yu J; Lo KW; Kang W;
    J Pathol; 2023 Feb; 259(2):205-219. PubMed ID: 36373776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SGLT2 promotes pancreatic cancer progression by activating the Hippo signaling pathway via the hnRNPK-YAP1 axis.
    Ren D; Sun Y; Zhang D; Li D; Liu Z; Jin X; Wu H
    Cancer Lett; 2021 Oct; 519():277-288. PubMed ID: 34314754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.